The first 10 drugs included in the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act (IRA) were ...
The pharmaceutical industry suffered a huge legislative defeat last year when Congress and President Joe Biden enacted a law ...
Medicare’s drug price negotiation program violates the Constitution and must be struck down, Novartis Pharmaceuticals said in ...
We all know that policymakers are increasingly focused on lowering drug costs. From the Inflation Reductions Act's Medicare price negotiations (aka price controls) to the recent proposals directed at ...
AbbVie Inc. agreed to acquire ImmunoGen Inc. for a total equity value of $10.1 billion in a move aimed at gaining access to ...
Uncertainty about the impact of Medicare drug price negotiations and the Federal Trade Commission’s (FTC) scrutiny of M&A deals in the sector remain overhangs.
Through the deal, AbbVie gains Elahere, which is approved for ovarian cancer patients who have received previous therapies, ...
In terms of therapeutic breakthroughs, Isasi suggested that the drug price negotiation program’s current structure is an effective deterrent from drugmakers’ low-impact profit chasing. “In ...
PHARMA FRETS OVER HIV DRUG LAWSUIT — The drug industry and its business allies warn that the outcome of a California lawsuit targeting a type of HIV medication could have a ripple effect on how ...
There might just be a silver lining for Johnson & Johnson in the FDA's recent approval of Amgen’s Stelara biosimilar. That’s because the coming entry of a cheaper copycat presents J&J with an ...
Here is a timeline of climate change negotiations as COP28 starts in Dubai.
Through the deal, AbbVie gains Elahere that is approved for ovarian cancer patients who have received previous therapies, and ...
